Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MEG3
   Synonyms MEG3, FP504, GTL2, LINC00023, NCRNA00023, PRO0518, PRO2160, onco-lncRNA-83, prebp1
   Region GRCh38_14:100779410-100861031    Sequence
   Ensembl ENSG00000214548
   RefSeq NR_002766
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name gastric cardia adenocarcinoma
   ICD-0-3 C16.0  M8140/3
   Methods qPCR, Cell transfection, Cell proliferation assay etc.
   Sample GCA tissues, cell lines (MKN45, SGC7901, BGC823, and AGS)
   Expression Pattern down-regulated
   Function Description

MEG3 and miR-770 was significantly downregulated in GCA patients and cell lines. Overexpression of MEG3 and miR-770 inhibited gastric cancer cell proliferation and invasion in vitro. Furthermore, the expression level of MEG3 and miR-770 was significantly increased in cancer cells after treated with 5-Aza-dC. The aberrant hypermethylation of proximal promoter and enhancer region of MEG3 was detected in GCA tissues.

   Pubmed ID 28345805
   Year 2017
   Title Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma.
   External Links
   Links for  MEG3 GenBank       HGNC       lncrnadb       Noncode
   Links for  gastric cardia adenocarcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.